Surfactin produced by Bacillus subtilis is a powerful biosurfactant in food,
cosmetics, and
pesticide industries. However, its suitability in wound healing applications is uncertain. In this article, we determined the effects of
surfactin A from B. subtilis on wound healing, angiogenesis, cell migration, inflammatory response, and
scar formation. The results indicated that 80.65 ± 2.03% of
surfactin A-treated
wounds were closed, whereas 44.30 ± 4.26% of the vehicle-treated
wound areas remained open on day 7 (P < 0.05). In mechanisms, it upregulated the expression of
hypoxia-inducible factor-1α (HIF-1α) and
vascular endothelial growth factor (
VEGF), accelerated keratinocyte migration through
mitogen-activated protein kinase (MAPK) and nuclear factor-κB (NF-κB) signaling pathways, and regulated the secretion of proinflammatory
cytokines and macrophage phenotypic switch. More attractive,
surfactin A showed a seductive capability to inhibit
scar tissue formation by affecting the expression of α-smooth muscle actin (α-SMA) and
transforming growth factor (TGF-β). Overall, the study revealed a new function and potential of
surfactin A as an affordable and efficient wound healing
drug.